Omada Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on June 9, 2025. Omada Health, Inc. (OMDA) is a Delaware corporation reporting the completion of its initial public offering (IPO) and the concurrent amendment of its corporate governance documents.
Key Financial Metrics
The filing details the financial specifics of the IPO but does not provide historical revenue, profit, cash flow, or debt metrics.
- Shares Sold: 9,085,000 shares of common stock.
- Offering Price: $19.00 per share.
- Gross Proceeds: $172,615,000 (before underwriting discounts, commissions, and offering expenses).
- Underwriter Option: The underwriters exercised their option in full to purchase an additional 1,185,000 shares.
Material Changes
The primary material change is the transition from a private to a public company. On June 9, 2025, the Company:
- Filed a Restated Certificate of Incorporation with the State of Delaware.
- Implemented Amended and Restated Bylaws effective immediately prior to the IPO closing.
- Registered its common stock on The Nasdaq Stock Market LLC under the symbol "OMDA".
Guidance, Outlook, and Risks
This filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors. It references the final prospectus dated June 5, 2025, for a detailed description of the capital stock provisions and associated risks.
Investor Verification Checklist
- Verify the net proceeds after deducting underwriting discounts and estimated offering expenses.
- Review the "Description of Capital Stock" section in the final prospectus (File No. 333-287156) for details on voting rights and anti-takeover provisions.
- Confirm the lock-up period restrictions for existing shareholders post-IPO.
- Examine the Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for changes to director election procedures or indemnification clauses.